PT964856E - Aminoacidos aromaticos biciclicos - Google Patents
Aminoacidos aromaticos biciclicosInfo
- Publication number
- PT964856E PT964856E PT98908063T PT98908063T PT964856E PT 964856 E PT964856 E PT 964856E PT 98908063 T PT98908063 T PT 98908063T PT 98908063 T PT98908063 T PT 98908063T PT 964856 E PT964856 E PT 964856E
- Authority
- PT
- Portugal
- Prior art keywords
- amino acids
- aromatic amino
- bacterial aromatic
- bacterial
- acids
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19705450A DE19705450A1 (de) | 1997-02-13 | 1997-02-13 | Bicyclische aromatische Aminosäuren |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT964856E true PT964856E (pt) | 2003-02-28 |
Family
ID=7820093
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT98908063T PT964856E (pt) | 1997-02-13 | 1998-02-06 | Aminoacidos aromaticos biciclicos |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP0964856B1 (pt) |
| JP (1) | JP4327257B2 (pt) |
| KR (1) | KR20000071030A (pt) |
| CN (1) | CN1085205C (pt) |
| AR (1) | AR010894A1 (pt) |
| AT (1) | ATE225776T1 (pt) |
| AU (1) | AU735313B2 (pt) |
| BR (1) | BR9807345A (pt) |
| CA (1) | CA2280727C (pt) |
| CY (1) | CY2341B1 (pt) |
| CZ (1) | CZ297366B6 (pt) |
| DE (2) | DE19705450A1 (pt) |
| DK (1) | DK0964856T3 (pt) |
| ES (1) | ES2183332T3 (pt) |
| HU (1) | HUP0001138A3 (pt) |
| ID (1) | ID22533A (pt) |
| NO (1) | NO313289B1 (pt) |
| PL (1) | PL335101A1 (pt) |
| PT (1) | PT964856E (pt) |
| RU (1) | RU2187506C2 (pt) |
| SI (1) | SI0964856T1 (pt) |
| SK (1) | SK284646B6 (pt) |
| TR (1) | TR199901962T2 (pt) |
| WO (1) | WO1998035949A1 (pt) |
| ZA (1) | ZA981178B (pt) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040063790A1 (en) * | 1996-05-31 | 2004-04-01 | The Scripps Research Institute | Methods for inhibition of angiogenesis |
| ATE542797T1 (de) | 1998-04-09 | 2012-02-15 | Meiji Seika Pharma Co Ltd | Aminopiperidinderivate als integrin alpha v beta 3 antagonisten |
| PL351279A1 (en) | 1999-04-13 | 2003-04-07 | Abbott Gmbh & Co Kg | Integrin receptor ligands |
| AU6316900A (en) | 1999-08-05 | 2001-03-05 | Meiji Seika Kaisha Ltd. | Omega-amino-alpha-hydroxycarboxylic acid derivatives having integrin alphavbeta3antagonism |
| EP1244616A1 (en) * | 1999-12-24 | 2002-10-02 | SmithKline Beecham plc | (hetero)bicyclylmethanesulfonylamino-substituted hydroxamic acid derivatives |
| DE60101351T2 (de) * | 2000-01-25 | 2004-10-07 | Kaneka Corp | Verfahren zur herstellung optisch aktiver, n-substituierter azetidin-2-carbonsäuren |
| CN100571772C (zh) * | 2000-11-01 | 2009-12-23 | 默克专利有限公司 | 整联蛋白受体αvβ3和/或αvβ5的拮抗剂在制备用于治疗眼疾的药物中的用途 |
| ATE415163T1 (de) * | 2000-11-01 | 2008-12-15 | Merck Patent Gmbh | Verfahren und zusammensetzungen zur behandlung von augenerkrankungen |
| EP1404860B8 (en) | 2001-05-30 | 2013-12-25 | The Scripps Research Institute | Delivery system for nucleic acids |
| HUP0401605A3 (en) | 2001-08-01 | 2012-09-28 | Merck Patent Gmbh | Integrin inhibitors for the treatment of eye diseases |
| RU2004127577A (ru) * | 2002-02-14 | 2005-05-27 | Мерк Патент ГмбХ (DE) | Способы и композиции для лечения заболеваний глаз |
| FR2847254B1 (fr) * | 2002-11-19 | 2005-01-28 | Aventis Pharma Sa | Nouveaux derives antagonistes du recepteur de la vitronectine, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les refermant |
| DE10305784A1 (de) * | 2003-02-12 | 2004-08-26 | Merck Patent Gmbh | Verfahren zur Herstellug bicyclischer aromatischer Aminosäuren sowie deren Zwischenprodukte |
| DE10337863A1 (de) | 2003-08-18 | 2005-03-17 | Merck Patent Gmbh | Verwendung von Chromen-4-on-Derivaten |
| EP2484364B1 (en) * | 2004-06-04 | 2014-02-19 | The Scripps Research Institute | Compositions for treatment of neovascular diseases |
| UA87854C2 (en) | 2004-06-07 | 2009-08-25 | Мерк Энд Ко., Инк. | N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators |
| PL2380881T3 (pl) * | 2008-12-26 | 2017-07-31 | Sumitomo Dainippon Pharma Co., Ltd. | Nowy bicykliczny związek heterocykliczny |
| WO2011024987A1 (ja) * | 2009-08-31 | 2011-03-03 | 塩野義製薬株式会社 | 芳香族縮合へテロ環誘導体およびそれらを含有する医薬組成物 |
| AR090259A1 (es) | 2012-03-06 | 2014-10-29 | Boehringer Ingelheim Int | Inhibidores de benzodioxano de la produccion de leucotrieno para terapia de combinacion |
| TW201416354A (zh) | 2012-07-17 | 2014-05-01 | Boehringer Ingelheim Int | 白三烯生成抑制劑 |
| EP3022194B1 (en) | 2013-07-15 | 2017-05-17 | Boehringer Ingelheim International GmbH | Inhibitors of leukotriene production |
| WO2015009609A1 (en) | 2013-07-15 | 2015-01-22 | Boehringer Ingelheim International Gmbh | Inhibitors of leukotriene production |
| MX2016015467A (es) | 2014-05-30 | 2017-03-23 | Pfizer | Derivados de carbonitrilo como moduladores selectivos del receptor de androgenos. |
| WO2023275715A1 (en) | 2021-06-30 | 2023-01-05 | Pfizer Inc. | Metabolites of selective androgen receptor modulators |
| CA3221177A1 (en) | 2021-11-01 | 2023-05-04 | Meghan Kerrisk Campbell | Benzodioxane modulators of leukotriene a4 hydrolase (lta4h) for prevention and treatment of aging-associated diseases |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3151690A1 (de) * | 1981-12-29 | 1983-07-07 | Hoechst Ag, 6230 Frankfurt | "neue derivate bicyclischer aminosaeuren, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie neue bicyclische aminosaeuren als zwischenstufen und verfahren zu deren herstellung" |
| FR2674854B1 (fr) * | 1991-04-04 | 1995-03-03 | Bouchara | Nouvelles quinolones leur procede de preparation et les compositions pharmaceutiques en refermant. |
| US5648368A (en) * | 1992-12-01 | 1997-07-15 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
| DE69528829T2 (de) * | 1994-05-27 | 2003-08-07 | Merck & Co., Inc. | Präparate zur hemmung der durch osteoklasten vermittelten knochenresorption |
| DE19548709A1 (de) * | 1995-12-23 | 1997-07-03 | Merck Patent Gmbh | Tyrosinderivate |
| DE19654483A1 (de) * | 1996-06-28 | 1998-01-02 | Merck Patent Gmbh | Phenylalanin-Derivate |
| EP0907637A1 (de) * | 1996-06-28 | 1999-04-14 | MERCK PATENT GmbH | Phenylalanin-derivate als integrin-inhibitoren |
-
1997
- 1997-02-13 DE DE19705450A patent/DE19705450A1/de not_active Withdrawn
-
1998
- 1998-02-06 BR BR9807345A patent/BR9807345A/pt not_active Application Discontinuation
- 1998-02-06 TR TR1999/01962T patent/TR199901962T2/xx unknown
- 1998-02-06 AT AT98908063T patent/ATE225776T1/de not_active IP Right Cessation
- 1998-02-06 JP JP53530398A patent/JP4327257B2/ja not_active Expired - Fee Related
- 1998-02-06 RU RU99119223/04A patent/RU2187506C2/ru not_active IP Right Cessation
- 1998-02-06 ES ES98908063T patent/ES2183332T3/es not_active Expired - Lifetime
- 1998-02-06 EP EP98908063A patent/EP0964856B1/de not_active Expired - Lifetime
- 1998-02-06 HU HU0001138A patent/HUP0001138A3/hu unknown
- 1998-02-06 CA CA002280727A patent/CA2280727C/en not_active Expired - Fee Related
- 1998-02-06 SI SI9830304T patent/SI0964856T1/xx unknown
- 1998-02-06 ID IDW990812A patent/ID22533A/id unknown
- 1998-02-06 KR KR1019997007297A patent/KR20000071030A/ko not_active Ceased
- 1998-02-06 SK SK1071-99A patent/SK284646B6/sk unknown
- 1998-02-06 AU AU66206/98A patent/AU735313B2/en not_active Ceased
- 1998-02-06 DK DK98908063T patent/DK0964856T3/da active
- 1998-02-06 CZ CZ0287599A patent/CZ297366B6/cs not_active IP Right Cessation
- 1998-02-06 PL PL98335101A patent/PL335101A1/xx unknown
- 1998-02-06 DE DE59805895T patent/DE59805895D1/de not_active Expired - Lifetime
- 1998-02-06 WO PCT/EP1998/000636 patent/WO1998035949A1/de not_active Ceased
- 1998-02-06 PT PT98908063T patent/PT964856E/pt unknown
- 1998-02-06 CN CN98803959A patent/CN1085205C/zh not_active Expired - Fee Related
- 1998-02-12 ZA ZA981178A patent/ZA981178B/xx unknown
- 1998-02-13 AR ARP980100654A patent/AR010894A1/es not_active Application Discontinuation
-
1999
- 1999-08-12 NO NO19993901A patent/NO313289B1/no not_active IP Right Cessation
-
2003
- 2003-03-17 CY CY0300028A patent/CY2341B1/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT964856E (pt) | Aminoacidos aromaticos biciclicos | |
| ATE238984T1 (de) | Sulfonylaminocarbonsäuren | |
| DE69837776D1 (de) | Etiketten | |
| NO985680D0 (no) | Peptidderivater | |
| DK0904288T3 (da) | Patogent Escherichia coli-associeret protein | |
| NO983849L (no) | Peptidderivater | |
| AU6760798A (en) | Bax inhibitor proteins | |
| EP1018551A4 (en) | MEGSIN PROTEIN | |
| EE9900445A (et) | Bakteriaalsed plasmiidid | |
| TR199701666A3 (tr) | Sismanliga karsi proteinler | |
| KR970052661U (ko) | 라벨 | |
| DE69802830D1 (de) | Aromatische substituierte naphtopyranen | |
| SE9602844D0 (sv) | Amino acid conjugate | |
| DK1017798T3 (da) | Lunasinpeptider | |
| IL122435A0 (en) | Amino butyric acids fungicides | |
| NO20000976D0 (no) | Peptider | |
| GB9704252D0 (en) | Novel protein | |
| GB9703850D0 (en) | Novel protein | |
| GB9703827D0 (en) | Novel protein | |
| GB9706119D0 (en) | Novel protein | |
| UA1739S (uk) | Етикетка | |
| UA1760S (uk) | Етикетка | |
| UA1723S (uk) | Етикетка | |
| UA1724S (uk) | Етикетка | |
| UA1761S (uk) | Етикетка |